肺癌合并静脉血栓栓塞的研究概况

Research Survey of Lung Cancer Combined with Venous Thromboembolism

恶性肿瘤患者容易并发血栓性疾病,静脉血栓栓塞目前已成为恶性肿瘤患者最常见的并发症之一,是除恶性肿瘤本身引起患者死亡的第二大原因。肺癌是常见的合并静脉血栓栓塞的肿瘤类型,肿瘤自身因素及肺癌治疗的相关因素促进了血栓的形成,早期识别肺癌患者静脉血栓栓塞发生的风险,采取充分的预防措施以改善预后至关重要。近年来国内外关于肺癌并发血栓形成的机理和防治研究有了不少进展。本文就肺癌合并静脉血栓栓塞的发生机制、临床表现、预防、治疗等研究进展进行综述。

Thrombosis, especially venous thromboembolism, which is the second leading cause of death in addition to cancer itself, the most common complication in patients with cancer especially. Lung cancer is a common tumor combined with venous thromboembolism which is promoted by cancer itself and its treatment, so it is important to identify venous thromboembolism in cancer patients to take adequate precautions to improve the prognosis. In recent years, there are many studies about the mechanism and treatment of lung cancer complicated with thrombosis. We give an overview of the pathogenesis, clinical manifestations, prevention and treatment of patients with lung cancer complicated with thrombosis.